1 Digital Healthcare Stock To Avoid
Health services IT company TRxADE HEALTH, Inc. (NASDAQ:MEDS) played a vital role during the pandemic, making remote care and tests available to patients with its digital healthcare wing. While the effects of the pandemic are largely in the rearview mirror, TRxADE remains a prominent player in the pharmaceutical industry. » Read more about: 1 Digital Healthcare Stock To Avoid »
Read More
1 ETF To Own Forever: Why Buy SPY?
When it comes to broad index funds that follow the Standard & Poor’s 500, many say the SPY ETF is hard to beat.
As a product of State Street Global Advisors, SPY is a uniquely attractive exchange traded fund for many investors with different strategies, diverse backgrounds and levels of capital.
» Read more about: 1 ETF To Own Forever: Why Buy SPY? »
Read More
Stunning Win-Win Deal For Top Magnificent 7 Stocks
In stunning news announced earlier this week, Apple revealed that it is looking to partner with Alphabet to allow Google’s Gemini to power iPhone AI features.
The announcement was stunning on numerous counts. Notably, both stocks ended the trading higher on the news. That fact alone suggests that the market interprets the deal to be a win-win.
» Read more about: Stunning Win-Win Deal For Top Magnificent 7 Stocks »
Read MoreThe Burst
Market Commentary: Billionaires Loading Up On 1 Stock-Split Stock
A former hedge fund analyst commented that Nvidia was “either a fraud or 100% a short” yet billionaires continue to pile into this chip maker, why? We dived down the rabbit hole to find out.
Read MoreThe Spotlight
The Daily
Is Fidelity Advisor Equity Growth M (FAEGX) a Strong Mutual Fund Pick Right Now?
On the lookout for a Large Cap Growth fund? Starting with Fidelity Advisor Equity Growth M (FAEGX) is one possibility. FAEGX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance.
FAEGX is part of the Large Cap Growth section,